Full text not available from this repository.

Abstract

Yersinia ruckeri causes significant losses in farmed salmonids (Tobback et al., 2009) and is the causative agent of both enteric red mouth disease in rainbow trout in the Northern Hemisphere (Tobback et al., 2009) and yersiniosis in Atlantic salmon (Salmo salar) in the Southern Hemisphere (Carson & Wilson, 2009). The first commercial yersiniosis vaccine was licensed in 1976 as formalin-killed whole cells of Y. ruckeri (see Bridle, Koop, & Nowak, 2012). Formalin inactivation is most commonly used for commercial fish vaccine production (Sommerset, Krossøy, Biering, & Frost, 2005). Inactivation of bacteria by formalin influences the physicochemical characteristics of surface antigens and may reduce protective efficacy against pathogenic bacteria (Tu, Chu, Zhuang, & Lu, 2010).

Item Type:	Article
Authors/Creators:	Nguyen, TD and Crosbie, PBB and Nowak, BF and Bridle, AR
Keywords:	vaccination, Salmo salar, Yersinia ruckeri, yersiniosis
Journal or Publication Title:	Journal of Fish Diseases
Publisher:	Blackwell Publishing Ltd
ISSN:	0140-7775
DOI / ID Number:	10.1111/jfd.12803
Copyright Information:	Copyright 2018 John Wiley & Sons Ltd
Related URLs:	UTAS Profile: Nowak, BF Google Scholar: Bridle, AR UTAS Profile: Bridle, AR
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page